Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 24 | 2020 | 918 | 4.230 |
Why?
|
| Lung Neoplasms | 22 | 2021 | 412 | 3.600 |
Why?
|
| Lung Diseases | 4 | 2020 | 46 | 1.920 |
Why?
|
| Early Detection of Cancer | 9 | 2019 | 90 | 1.440 |
Why?
|
| Radiography, Thoracic | 5 | 2020 | 45 | 1.420 |
Why?
|
| Mass Screening | 9 | 2019 | 263 | 1.190 |
Why?
|
| Radiation Dosage | 6 | 2019 | 84 | 0.890 |
Why?
|
| Lung | 10 | 2020 | 249 | 0.870 |
Why?
|
| Incidental Findings | 3 | 2018 | 25 | 0.760 |
Why?
|
| Multiple Pulmonary Nodules | 2 | 2015 | 2 | 0.630 |
Why?
|
| Pleural Effusion | 1 | 2015 | 13 | 0.520 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2015 | 17 | 0.520 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 85 | 0.510 |
Why?
|
| Humans | 37 | 2021 | 32005 | 0.510 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2021 | 145 | 0.470 |
Why?
|
| Smoking | 6 | 2021 | 497 | 0.470 |
Why?
|
| Coronary Artery Disease | 2 | 2015 | 401 | 0.470 |
Why?
|
| Carcinoma | 1 | 2015 | 91 | 0.460 |
Why?
|
| Middle Aged | 18 | 2021 | 11817 | 0.350 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 510 | 0.340 |
Why?
|
| Aged | 15 | 2019 | 10301 | 0.300 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 101 | 0.270 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2019 | 19 | 0.260 |
Why?
|
| United States | 9 | 2021 | 3939 | 0.260 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2005 | 11 | 0.250 |
Why?
|
| Aneurysm, Dissecting | 1 | 2005 | 12 | 0.250 |
Why?
|
| Male | 17 | 2021 | 19165 | 0.240 |
Why?
|
| Female | 17 | 2021 | 19959 | 0.240 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 49 | 0.240 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2014 | 6 | 0.240 |
Why?
|
| Coronary Disease | 1 | 2005 | 211 | 0.230 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 18 | 0.210 |
Why?
|
| Pericardium | 1 | 2003 | 52 | 0.210 |
Why?
|
| Thoracic Diseases | 1 | 2002 | 4 | 0.200 |
Why?
|
| Sarcoidosis | 1 | 2002 | 28 | 0.200 |
Why?
|
| Myocardium | 1 | 2003 | 186 | 0.200 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 876 | 0.180 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 517 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2005 | 1328 | 0.180 |
Why?
|
| Retrospective Studies | 4 | 2019 | 3509 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 120 | 0.180 |
Why?
|
| Sarcoidosis, Pulmonary | 2 | 2015 | 4 | 0.180 |
Why?
|
| Access to Information | 1 | 2020 | 13 | 0.180 |
Why?
|
| Receptors, Nicotinic | 1 | 2021 | 59 | 0.180 |
Why?
|
| Smoking Cessation | 2 | 2020 | 198 | 0.170 |
Why?
|
| Telemedicine | 1 | 2020 | 102 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2020 | 156 | 0.160 |
Why?
|
| Mediastinal Diseases | 1 | 2018 | 4 | 0.160 |
Why?
|
| Sarcopenia | 1 | 2019 | 64 | 0.160 |
Why?
|
| Digestive System Diseases | 1 | 2018 | 6 | 0.150 |
Why?
|
| Thyroid Nodule | 1 | 2018 | 7 | 0.150 |
Why?
|
| Mediastinal Neoplasms | 1 | 2018 | 13 | 0.150 |
Why?
|
| Medical Oncology | 1 | 2019 | 86 | 0.150 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 447 | 0.150 |
Why?
|
| Prevalence | 4 | 2019 | 981 | 0.150 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 58 | 0.150 |
Why?
|
| Neoplasms | 2 | 2020 | 726 | 0.150 |
Why?
|
| False Positive Reactions | 2 | 2014 | 29 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 835 | 0.140 |
Why?
|
| Computer Communication Networks | 1 | 2016 | 4 | 0.140 |
Why?
|
| Body Surface Area | 1 | 2016 | 15 | 0.140 |
Why?
|
| Algorithms | 1 | 2019 | 495 | 0.130 |
Why?
|
| Reference Values | 1 | 2016 | 246 | 0.130 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2015 | 1 | 0.130 |
Why?
|
| Pneumoconiosis | 1 | 2015 | 1 | 0.130 |
Why?
|
| Medical Illustration | 1 | 2015 | 6 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2015 | 898 | 0.130 |
Why?
|
| Bronchiolitis | 1 | 2015 | 3 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 10 | 0.120 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 48 | 0.120 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 27 | 0.120 |
Why?
|
| Coronary Circulation | 1 | 2015 | 43 | 0.120 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 27 | 0.120 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 63 | 0.120 |
Why?
|
| Dobutamine | 1 | 2015 | 69 | 0.120 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 103 | 0.120 |
Why?
|
| Prediabetic State | 1 | 2015 | 65 | 0.120 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 107 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 158 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 43 | 0.110 |
Why?
|
| Incidence | 2 | 2021 | 1199 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 245 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 183 | 0.110 |
Why?
|
| Cause of Death | 1 | 2013 | 236 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 407 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2015 | 1426 | 0.100 |
Why?
|
| Emphysema | 1 | 2012 | 12 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 353 | 0.100 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2011 | 7 | 0.100 |
Why?
|
| Central Venous Pressure | 1 | 2011 | 4 | 0.100 |
Why?
|
| Water-Electrolyte Balance | 1 | 2011 | 16 | 0.100 |
Why?
|
| Fluid Therapy | 1 | 2011 | 24 | 0.090 |
Why?
|
| Acute Lung Injury | 1 | 2011 | 33 | 0.090 |
Why?
|
| Risk Factors | 5 | 2021 | 3876 | 0.090 |
Why?
|
| Contusions | 1 | 2011 | 41 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 185 | 0.090 |
Why?
|
| Minority Groups | 1 | 2011 | 78 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 1128 | 0.090 |
Why?
|
| Patient Selection | 1 | 2011 | 276 | 0.080 |
Why?
|
| Bronchi | 1 | 2009 | 33 | 0.080 |
Why?
|
| Contrast Media | 2 | 2015 | 138 | 0.080 |
Why?
|
| Foreign Bodies | 1 | 2009 | 30 | 0.080 |
Why?
|
| Trachea | 1 | 2009 | 52 | 0.080 |
Why?
|
| Heart Failure | 1 | 2015 | 639 | 0.080 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 195 | 0.080 |
Why?
|
| Ethnic Groups | 1 | 2011 | 476 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 3990 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 762 | 0.070 |
Why?
|
| Age Factors | 3 | 2015 | 1188 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2005 | 26 | 0.060 |
Why?
|
| Hematoma | 1 | 2005 | 27 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 123 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 226 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2003 | 6 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 881 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 2002 | 10 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 220 | 0.050 |
Why?
|
| Confidentiality | 1 | 2020 | 29 | 0.050 |
Why?
|
| RNA | 1 | 2021 | 92 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2017 | 2282 | 0.040 |
Why?
|
| Patient Participation | 1 | 2020 | 82 | 0.040 |
Why?
|
| Genotype | 1 | 2021 | 733 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 160 | 0.040 |
Why?
|
| Mediastinum | 1 | 2018 | 14 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 217 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 29 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2018 | 15 | 0.040 |
Why?
|
| Esophagus | 1 | 2018 | 22 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2018 | 35 | 0.040 |
Why?
|
| Decision Making | 1 | 2019 | 195 | 0.040 |
Why?
|
| Program Development | 1 | 2018 | 96 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2018 | 107 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2018 | 185 | 0.040 |
Why?
|
| Spirometry | 1 | 2017 | 27 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2017 | 40 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 87 | 0.040 |
Why?
|
| Adult | 3 | 2015 | 9345 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 58 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 154 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2014 | 81 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 158 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 376 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 463 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 582 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 663 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2015 | 494 | 0.030 |
Why?
|
| Education | 1 | 2012 | 38 | 0.030 |
Why?
|
| Observer Variation | 1 | 2012 | 105 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 877 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1817 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 99 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1514 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 2011 | 50 | 0.020 |
Why?
|
| Lung Injury | 1 | 2011 | 68 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 313 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 355 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 423 | 0.020 |
Why?
|
| Respiratory Aspiration | 1 | 2009 | 21 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2009 | 29 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2009 | 47 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 2149 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2265 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 2005 | 5 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 2005 | 5 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2005 | 31 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 163 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 130 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 3306 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 379 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 765 | 0.010 |
Why?
|